Radium-223 Therapy Lowers PD-L1 in Prostate Cancer Bone Metastases, PET Study Shows
A prospective imaging study shows that radium-223 significantly reduces PD-L1 expression and depletes immune cells in prostate cancer bone metastases, ...
A prospective imaging study shows that radium-223 significantly reduces PD-L1 expression and depletes immune cells in prostate cancer bone metastases, ...
New ahead-of-print studies in The Journal of Nuclear Medicine showcase immune-cell PET imaging, long-acting radiopharmaceutical therapies, and validated quantitative PET ...
New research in Nature Cancer shows that the common commensal fungus Nakaseomyces glabratus is enriched in the feces and tumors ...
Multi-omic profiling of enzalutamide-resistant prostate cancer cells has revealed rewired lipid, glutamine and mitochondrial metabolism that creates druggable vulnerabilities and ...
For nearly four decades, KRAS occupied a paradoxical position in cancer biology: it was the most intensively studied oncogene in ...
A hidden layer of genetic regulation in prostate cancer may offer researchers a new way to weaken aggressive tumors without ...
In a groundbreaking study published in the Proceedings of the National Academy of Sciences, researchers at the University of Michigan ...
In a groundbreaking study that advances the understanding of prostate cancer, researchers have employed histology-resolved proteomics to elucidate the distinctive ...
The landscape of prostate cancer diagnosis and management has undergone a remarkable transformation over the past few decades, with prostate-specific ...
Success! An email was just sent to confirm your subscription. Please find the email now and click 'Confirm Follow' to start subscribing.
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine